Showing 301 - 320 results of 145,816 for search '(( 5 w decrease ) OR ((( 10 ((nn decrease) OR (a decrease)) ) OR ( 2 step decrease ))))', query time: 0.98s Refine Results
  1. 301
  2. 302
  3. 303
  4. 304
  5. 305
  6. 306
  7. 307
  8. 308
  9. 309
  10. 310

    Trial profile. by Chanel Avenant (409756)

    Published 2024
    “…We measured testosterone by UHPLC-MS/MS and SHBG by immunoassay in matched pairs of serum samples collected at baseline (D0) and at peak serum progestin levels at 25 weeks post initiation (25W) (n = 214–218 pairs). Both contraceptives substantially decreased, from D0 to 25W, the total testosterone [DMPA-IM D0 0.560, 25W 0.423 nmol/L, -24.3% (p < 0.0001); NET-EN D0 0.551, 25W 0.253 nmol/L, -54.1%, (p < 0.0001)], SHBG [DMPA-IM D0 45.0, 25W 32.7 nmol/L, -29.8% (p < 0.0001); NET-EN D0 50.2, 25W 17.6 nmol/L, -65.1% (p < 0.0001)], and calculated free testosterone levels [DMPA-IM D0 6.87, 25W 5.38 pmol/L, -17.2% (p = 0.0371); NET-EN D0 6.00, 25W 3.70, -40.0% (p < 0.0001)]. …”
  11. 311
  12. 312
  13. 313
  14. 314
  15. 315

    Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1<i>H</i>‑Indol-3-yl)‑1<i>H</i>‑imidazol-4-yl)(3,4,5-trimethoxyphenyl) Methanone (ABI-231) Analogues Targeting... by Qinghui Wang (2042065)

    Published 2019
    “…In vitro, biological studies showed that new ABI-231 analogues disrupt tubulin polymerization, promote microtubule fragmentation, and inhibit cancer cell migration. In vivo, analogue <b>10bb</b> not only significantly inhibits primary tumor growth and decreases tumor metastasis in melanoma xenograft models but also shows a significant ability to overcome paclitaxel resistance in a taxane-resistant PC-3/TxR model. …”
  16. 316
  17. 317
  18. 318
  19. 319
  20. 320

    A heatmap of the -log10(adj.pvalues) from AME enrichment testing within increasing and decreasing sites. by Spencer L. Nystrom (8730641)

    Published 2021
    “…<p>A heatmap of the -log10(adj.pvalues) from AME enrichment testing within increasing and decreasing sites.…”